Filippo Acconcia

Filippo Acconcia

Oct 14, 2017

Group 6 Copy 106
1
Please wait...

About This Project

70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can we prevent the transmission of BRCA mutations?

Women with the BRCA gene mutation have an 80% risk of developing breast or ovarian cancer. Most research...

Evaluating the Nutritional Status in Captive Saddle-billed Storks

Saddle-billed Storks are large, charismatic birds that are rare in captivity. The Dallas Zoo was the first...

You have mail: Stem Cell messages for fighting liver diseases

The use of stem cells is currently limited by issues including the risk of tumor formation or undesired...

Campaign Ended